US President Donald Trump is preparing to launch a sweeping investigation into foreign drug pricing practices, setting the stage for potential tariffs as he seeks to pressure other countries to pay as much as Americans do for pharmaceuticals, Bloomberg reported Wednesday.

According to Bloomberg, the probe would be initiated under Section 301 of the Trade Act of 1974—a powerful mechanism Trump has used before to impose tariffs on foreign entities deemed unfair to U.S. businesses. Advertisement

The White House declined to comment, and discussions remain private.

If implemented, the investigation could prompt tariffs or other trade actions against nations that negotiate lower drug prices—most of the developed world—escalating tensions across global pharmaceutical markets. Trump has long

See Full Page